Showing results (41-50 of 127) with videos related to
Sort By:
Pageof 13
Pain Medicine (Malden, Mass.)|January 28, 2016
Timeliness of Care Planning upon Initiation of Chronic Opioid Therapy for Chronic PainMichael Von Korff, Judith A Turner, Susan M Shortreed, et al.Infection and Immunity|March 6, 1998
The Haemophilus influenzae HtrA protein is a protective antigenS M Loosmore, Y P Yang, R Oomen, et al.Observational Studies|January 3, 2017
Electronic Health Records to Evaluate and Account for Non-response Bias: A Survey of Patients Using Chronic Opioid TherapySusan M Shortreed, Michael Von Korff, Stephen Thielke, et al.American Journal of Epidemiology|January 2, 2025
Adjusting for Selection Bias Due to Missing Eligibility Criteria in Emulated Target TrialsLuke Benz, Rajarshi Mukherjee, Rui Wang, et al.Pain|May 22, 2013
Optimizing prediction of back pain outcomesJudith A Turner, Susan M Shortreed, Kathleen W Saunders, et al.Journal of General Internal Medicine|September 14, 2014
Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant resultsJudith A Turner, Kathleen Saunders, Susan M Shortreed, et al.Infection and Immunity|September 1, 1997
Outer membrane protein D15 is conserved among Haemophilus influenzae species and may represent a universal protective antigen against invasive diseaseS M Loosmore, Y P Yang, D C Coleman, et al.The Journal of Pain|October 18, 2015
The Impact of Opioid Risk Reduction Initiatives on High-Dose Opioid Prescribing for Patients on Chronic Opioid TherapyMichael Von Korff, Sascha Dublin, Rod L Walker, et al.Suicide & Life-Threatening Behavior|March 26, 2018
Predicting Suicide Attempts for Racial and Ethnic Groups of Patients During Routine Clinical CareKaren J Coleman, Eric Johnson, Brian K Ahmedani, et al.Trials|December 10, 2019
Principles and procedures for data and safety monitoring in pragmatic clinical trialsGregory E Simon, Susan M Shortreed, Rebecca C Rossom, et al.Pageof 13